Immunotherapy Prolongs Survival in Patients with Rare Skin Cancer
A groundbreaking clinical study led by researchers at UCLA has revealed that pembrolizumab—a potent immunotherapy drug targeting the PD-1 receptor—can ...
Tag: PD-1 immune checkpoint inhibitor
Low-Dose Radiotherapy Combo Shows Promise in Head and Neck Cancer
In a groundbreaking advance for the treatment of head and neck cancers, researchers have unveiled promising results from a phase ...
Camrelizumab, Apatinib, Irinotecan: New Esophageal Cancer Therapy
In a groundbreaking advancement for esophageal cancer treatment, researchers have unveiled compelling evidence supporting the efficacy of camrelizumab combined with ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Warm seawater speeding up melting of ‘Doomsday Glacier,’ scientists warn
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!